Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 5
2004 5
2005 3
2006 8
2007 4
2008 8
2009 9
2010 6
2011 4
2012 6
2013 3
2014 8
2015 10
2016 8
2017 5
2018 3
2019 7
2020 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux GP, Hardwigsen J, Benkhatar Y, Derquenne F, Conti F. Saliba F, et al. Among authors: calmus y. Liver Int. 2022 Nov;42(11):2513-2523. doi: 10.1111/liv.15396. Epub 2022 Sep 1. Liver Int. 2022. PMID: 35962772 Free PMC article.
Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry.
Saliba F, Dharancy S, Salamé E, Conti F, Eyraud D, Radenne S, Antonini T, Guillaud O, Guguenheim J, Neau-Cransac M, Demartin E, Lasailly G, Duvoux C, Sobesky R, Coilly A, Tresson S, Cailliez V, Boillot O, Pageaux GP, Samuel D, Calmus Y, Dumortier J. Saliba F, et al. Among authors: calmus y. Liver Transpl. 2020 Nov;26(11):1465-1476. doi: 10.1002/lt.25879. Epub 2020 Oct 12. Liver Transpl. 2020. PMID: 32869469
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years.
Saliba F, Duvoux C, Dharancy S, Dumortier J, Calmus Y, Gugenheim J, Kamar N, Salamé E, Neau-Cransac M, Vanlemmens C, Durand F, Pageaux G, Leroy V, Hardwigsen J, Gharbi H, Masson C, Tindel M, Conti F. Saliba F, et al. Among authors: calmus y. Liver Transpl. 2019 Dec;25(12):1822-1832. doi: 10.1002/lt.25664. Liver Transpl. 2019. PMID: 31631501 Free PMC article.
Domino liver transplantation: the risk of disease recurrence.
Conti F, Mochel F, Calmus Y. Conti F, et al. Among authors: calmus y. Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):510-512. doi: 10.1016/j.clinre.2019.01.004. Epub 2019 Feb 14. Clin Res Hepatol Gastroenterol. 2019. PMID: 30773354 No abstract available.
108 results